 RALEIGH, N.C., Nov. 04, 2020 GLOBE NEWSWIRE -- BioDelivery Sciences International, Inc. NASDAQ: BDSI, a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that its Board of Directors has appointed Jeff Bailey as permanent Chief Executive Officer CEO, effective November 4, 2020. Jeff had previously been appointed as interim CEO in May 2020 while continuing to serve on the Board of Directors. 